These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 8246266)
1. Inhibition of the adherence of Pseudomonas aeruginosa to epithelial cells by IgG subclass antibodies. Morrin M; Reen DJ J Med Microbiol; 1993 Dec; 39(6):459-66. PubMed ID: 8246266 [TBL] [Abstract][Full Text] [Related]
2. Role of IgG subclass response to outer-membrane proteins in inhibiting adhesion of Pseudomonas aeruginosa to epithelial cells. Morrin M; Reen DJ J Med Microbiol; 1993 Dec; 39(6):467-72. PubMed ID: 8246267 [TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin-G subclasses in cystic fibrosis. IgG2 response to Pseudomonas aeruginosa lipopolysaccharide. Fick RB; Olchowski J; Squier SU; Merrill WW; Reynolds HY Am Rev Respir Dis; 1986 Mar; 133(3):418-22. PubMed ID: 3082264 [TBL] [Abstract][Full Text] [Related]
4. IgG subclass antibodies to Pseudomonas aeruginosa in sera from patients with chronic Ps. aeruginosa infection investigated by ELISA. Pressler T; Pedersen SS; Espersen F; Høiby N; Koch C Clin Exp Immunol; 1990 Sep; 81(3):428-34. PubMed ID: 2118845 [TBL] [Abstract][Full Text] [Related]
6. Serotype-specific serum IgG antibodies to lipopolysaccharides of Pseudomonas aeruginosa in cystic fibrosis: correlation to disease, subclass distribution, and experimental protective capacity. Schaad UB; Lang AB; Wedgwood J; Buehlamnn U; Fuerer E Pediatr Res; 1990 May; 27(5):508-13. PubMed ID: 2111907 [TBL] [Abstract][Full Text] [Related]
7. IgG subclass antibody responses to alginate from Pseudomonas aeruginosa in patients with cystic fibrosis and chronic P. aeruginosa infection. Pressler T; Pedersen SS; Espersen F; Høiby N; Koch C Pediatr Pulmonol; 1992 Sep; 14(1):44-51. PubMed ID: 1437343 [TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of the IgG and IgG subclass immune responses to chromosomal Pseudomonas aeruginosa beta-lactamase in serum from patients with cystic fibrosis by western blotting and laser scanning densitometry. Petersen TD; Ciofu O; Pressler T; Giwercman B; Pedersen SS; Høiby N Thorax; 1996 Jul; 51(7):733-8. PubMed ID: 8882082 [TBL] [Abstract][Full Text] [Related]
9. Serum IgA and IgG subclasses during treatment for acute respiratory exacerbation in cystic fibrosis: analysis of patients colonised with mucoid or non-mucoid strains of pseudomonas aeruginosa. Hassan J; Feighery C; Bresnihan B; Keogan M; Fitzgerald MX; Whelan A Immunol Invest; 1994 Jan; 23(1):1-13. PubMed ID: 8144195 [TBL] [Abstract][Full Text] [Related]
10. Association with phagocytic inhibition of anti-Pseudomonas aeruginosa immunoglobulin G antibody subclass levels in serum from patients with cystic fibrosis. Shryock TR; Mollé JS; Klinger JD; Thomassen MJ J Clin Microbiol; 1986 Mar; 23(3):513-6. PubMed ID: 3082922 [TBL] [Abstract][Full Text] [Related]
11. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses. Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330 [TBL] [Abstract][Full Text] [Related]
12. IgG subclass responses to Pseudomonas aeruginosa a- and b-type flagellins in patients with cystic fibrosis: a prospective study. Lagacé J; Péloquin L; Kermani P; Montie TC J Med Microbiol; 1995 Oct; 43(4):270-6. PubMed ID: 7562988 [TBL] [Abstract][Full Text] [Related]
13. Serum IgG and sputum IgA antibody to core lipopolysaccharide antigen from Pseudomonas cepacia in patients with cystic fibrosis. Nelson JW; Butler SL; Brown PH; Greening AP; Govan JR J Med Microbiol; 1993 Jul; 39(1):39-47. PubMed ID: 7686977 [TBL] [Abstract][Full Text] [Related]
14. Autoantibodies in serum and sputum from patients with cystic fibrosis. Schiøtz PO; Egeskjold EM; Høiby N; Permin H Acta Pathol Microbiol Scand C; 1979 Oct; 87(5):319-24. PubMed ID: 117671 [TBL] [Abstract][Full Text] [Related]
15. Bactericidal activity of serum from cystic fibrosis patients for Pseudomonas aeruginosa. Penketh AR; Pitt TL; Hodson ME; Batten JC J Med Microbiol; 1983 Nov; 16(4):401-8. PubMed ID: 6417338 [TBL] [Abstract][Full Text] [Related]
16. Relative increase in IgG antibodies to Pseudomonas aeruginosa 60-kDa GroEL in prediabetic patients with cystic fibrosis. Jensen P; Johansen HK; Lanng S; Høiby N Pediatr Res; 2001 Mar; 49(3):423-8. PubMed ID: 11228271 [TBL] [Abstract][Full Text] [Related]
17. Antilipopolysaccharide antibodies and differential diagnosis of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. Fomsgaard A; Dinesen B; Shand GH; Pressler T; Høiby N J Clin Microbiol; 1989 Jun; 27(6):1222-9. PubMed ID: 2502558 [TBL] [Abstract][Full Text] [Related]
18. Correlation between specific IgG subclass antibodies to Pseudomonas aeruginosa and opsonic activity in serum from patients with cystic fibrosis. Pressler T; Jensen ET; Espersen F; Pedersen SS; Høiby N; Koch C Pediatr Pulmonol; 1994 Jan; 17(1):31-40. PubMed ID: 8108174 [TBL] [Abstract][Full Text] [Related]
19. The immunoglobulin G subclass composition of immune complexes in cystic fibrosis. Implications for the pathogenesis of the Pseudomonas lung lesion. Hornick DB; Fick RB J Clin Invest; 1990 Oct; 86(4):1285-92. PubMed ID: 2120286 [TBL] [Abstract][Full Text] [Related]
20. The influence of allotypes on the IgG subclass response to chromosomal beta-lactamase of Pseudomonas aeruginosa in cystic fibrosis patients. Ciofu O; Pressler T; Pandey JP; Høiby N Clin Exp Immunol; 1997 Apr; 108(1):88-94. PubMed ID: 9097916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]